Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Yili Innovation Center Oceania, Lincoln University, Christchurch, New Zealand.
Trends Microbiol. 2020 Jul;28(7):578-593. doi: 10.1016/j.tim.2020.03.001. Epub 2020 Apr 6.
Lantibiotic salivaricins are polycyclic peptides containing lanthionine and/or β-methyllanthionine residues produced by certain strains of Streptococcus salivarius, which almost exclusively reside in the human oral cavity. The importance of these molecules stems from their antimicrobial activity towards relevant oral pathogens which has so far been applied through the development of salivaricin-producing probiotic strains. However, salivaricins may also prove to be of great value in the development of new and novel antibacterial therapies in this era of emerging antibiotic resistance. In this review, we describe the biosynthesis, antimicrobial activity, structure, and mode of action of the lantibiotic salivaricins characterized to date. Moreover, we also provide an expert opinion and suggestions for future development of this important field of microbiology.
唾液链球菌素是一类由某些唾液链球菌产生的具有环肽结构的多肽,包含[l]{.smallcaps}-高丝氨酸内酯和/或 β-甲基[l]{.smallcaps}-高丝氨酸内酯残基,几乎只存在于人类口腔中。这些分子的重要性源于其对相关口腔病原体的抗菌活性,迄今为止,这一特性已通过生产唾液链球菌素的益生菌菌株的开发得到了应用。然而,在当前抗生素耐药性不断出现的时代,唾液链球菌素也可能在开发新的抗菌疗法方面具有重要价值。在这篇综述中,我们描述了迄今为止已被描述的[l]{.smallcaps}-抗生素唾液链球菌素的生物合成、抗菌活性、结构和作用模式。此外,我们还为这一重要微生物学领域的未来发展提供了专家意见和建议。